SEO URLwww.firestrike.ai/deals/innovis-pharma-pharmapath-acquisition-2026
acquisitionAnnounced · Mar 10, 2026pharmaceuticalSource · Community DiscussionsArticle · Factual
PharmaPath acquires Innovis Pharma
David Najork · Founding Software Engineer
Published · Updated · 1 min read
Deal value
—
Target
Innovis Pharma
Marousi, Attica
Acquirer
PharmaPath
Full Acquisition
Status
Completed
PharmaPath agreed to acquire Innovis Pharma. Reported deal value: Undisclosed. Status: Completed. Sector: pharmaceutical. Target headquarters context: Marousi, Attica, Greece.
This page summarizes publicly available information about the transaction as of 2026-03-10. Figures and status may change as filings and press coverage update.
Copy URL PharmaPath has completed the acquisition of Innovis Pharma marking the creation of a new fully integrated Greek pharmaceutical group with more than 450 employees, combining R&D, manufacturing and commercial excellence
Deal timeline
Announced
Mar 10, 2026 · investorsinhealthcare.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in pharmaceutical. Figures and status may change as sources update.
Sources: investorsinhealthcare.com · Primary article · FireStrike proprietary index